Market Research Logo

Global Intravenous (IV) Solutions Market Analysis 2016 - Forecast to 2022

Global Intravenous (IV) Solutions Market Analysis 2016 - Forecast to 2022

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "Intravenous (IV) Solutions". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:

  • Market Sizing estimations and forecasts for 6 years across the given market segments
  • Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities, )
  • Strategic recommendations in key business segments based on the market estimations
  • Regional and country level market analysis
  • Competitive landscaping of major market players
  • Company profiling covering the financials, recent activities and the future strategies


1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations
2 Executive Summary
3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Intravenous (IV) Solutions Market by Nutrient
5.1 Introduction
5.2 Vitamins & minerals (salt and electrolyte)
5.3 Single dose amino acid solution
5.4 Parenteral lipid emulsion
5.5 Carbohydrates
5.6 Others (trace elements)
6 Intravenous (IV) Solutions Market by Type
6.1 Introduction
6.2 Peripheral Parenteral Nutrition (PPN)
6.3 Total Parenteral Nutrition (TPN)
7 Geographical Segmentation
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.2.6 Rest of Europe
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia Pacific
7.4 Rest of the World
7.4.1 Latin America
7.4.2 Middle East
7.4.3 Africa
7.4.4 Others
8 Vendor Landscaping
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiles
9.1 Widatra Bhakti
9.1.1 Business Overview
9.1.2 SWOT Analysis
9.1.3 Financial Overview
9.1.4 Strategy
9.1.5 Key Activities
9.2 Vifor Pharma
9.3 Terumo
9.4 Sichuan Kelun Pharmaceutical
9.5 Other prominent vendors
9.6 Omnicare
9.7 JW Life Science
9.8 Hospira
9.9 Grifols
9.10 Fresenius Kabi
9.11 Claris Lifesciences
9.12 Bioscrip
9.13 Baxter
9.14 B. Braun Melsungen
10 Appendix
11 Disclaimer
List of Tables
Table 1 Global Intravenous (IV) Solutions Market Analysis, by Region, 2013-2022 ($MN)
Table 2 Global Intravenous (IV) Solutions Market Analysis, by Nutrient, 2013-2022 ($MN)
Table 3 Global Vitamins & minerals (salt and electrolyte) Market Analysis, by Region, 2013-2022 ($MN)
Table 4 Global Single dose amino acid solution Market Analysis, by Region, 2013-2022 ($MN)
Table 5 Global Parenteral lipid emulsion Market Analysis, by Region, 2013-2022 ($MN)
Table 7 Global Carbohydrates Market Analysis, by Region, 2013-2022 ($MN)
Table 8 Global Others (trace elements) Market Analysis, by Region, 2013-2022 ($MN)
Table 9 Global Intravenous (IV) Solutions Market Analysis, by Type, 2013-2022 ($MN)
Table 10 Global Peripheral Parenteral Nutrition (PPN) Market Analysis, by Region, 2013-2022 ($MN)
Table 11 Global Total Parenteral Nutrition (TPN) Market Analysis, by Region, 2013-2022 ($MN)
Table 12 North America Intravenous (IV) Solutions Market Analysis, by Country, 2013-2022 ($MN)
Table 13 North America Intravenous (IV) Solutions Market Analysis, by Nutrient, 2013-2022 ($MN)
Table 14 North America Vitamins & minerals (salt and electrolyte) Market Analysis, by Country, 2013-2022 ($MN)
Table 15 North America Single dose amino acid solution Market Analysis, by Country, 2013-2022 ($MN)
Table 16 North America Parenteral lipid emulsion Market Analysis, by Country, 2013-2022 ($MN)
Table 17 North America Carbohydrates Market Analysis, by Country, 2013-2022 ($MN)
Table 18 North America Others (trace elements) Market Analysis, by Country, 2013-2022 ($MN)
Table 19 North America Intravenous (IV) Solutions Market Analysis, by Type, 2013-2022 ($MN)
Table 20 North America Peripheral Parenteral Nutrition (PPN) Market Analysis, by Country, 2013-2022 ($MN)
Table 21 North America Total Parenteral Nutrition (TPN) Market Analysis, by Country, 2013-2022 ($MN)
Table 22 Europe Intravenous (IV) Solutions Market Analysis, by Country, 2013-2022 ($MN)
Table 23 Europe Intravenous (IV) Solutions Market Analysis, by Nutrient, 2013-2022 ($MN)
Table 24 Europe Vitamins & minerals (salt and electrolyte) Market Analysis, by Country, 2013-2022 ($MN)
Table 25 Europe Single dose amino acid solution Market Analysis, by Country, 2013-2022 ($MN)
Table 26 Europe Parenteral lipid emulsion Market Analysis, by Country, 2013-2022 ($MN)
Table 27 Europe Carbohydrates Market Analysis, by Country, 2013-2022 ($MN)
Table 28 Europe Others (trace elements) Market Analysis, by Country, 2013-2022 ($MN)
Table 29 Europe Intravenous (IV) Solutions Market Analysis, by Type, 2013-2022 ($MN)
Table 30 Europe Peripheral Parenteral Nutrition (PPN) Market Analysis, by Country, 2013-2022 ($MN)
Table 31 Europe Total Parenteral Nutrition (TPN) Market Analysis, by Country, 2013-2022 ($MN)
Table 32 Asia Pacific Intravenous (IV) Solutions Market Analysis, by Country, 2013-2022 ($MN)
Table 33 Asia Pacific Intravenous (IV) Solutions Market Analysis, by Nutrient, 2013-2022 ($MN)
Table 34 Asia Pacific Vitamins & minerals (salt and electrolyte) Market Analysis, by Country, 2013-2022 ($MN)
Table 35 Asia Pacific Single dose amino acid solution Market Analysis, by Country, 2013-2022 ($MN)
Table 36 Asia Pacific Parenteral lipid emulsion Market Analysis, by Country, 2013-2022 ($MN)
Table 37 Asia Pacific Carbohydrates Market Analysis, by Country, 2013-2022 ($MN)
Table 38 Asia Pacific Others (trace elements) Market Analysis, by Country, 2013-2022 ($MN)
Table 39 Asia Pacific Intravenous (IV) Solutions Market Analysis, by Type, 2013-2022 ($MN)
Table 40 Asia Pacific Peripheral Parenteral Nutrition (PPN) Market Analysis, by Country, 2013-2022 ($MN)
Table 41 Asia Pacific Total Parenteral Nutrition (TPN) Market Analysis, by Country, 2013-2022 ($MN)
Table 42 RoW Intravenous (IV) Solutions Market Analysis, by Country, 2013-2022 ($MN)
Table 43 RoW Intravenous (IV) Solutions Market Analysis, by Nutrient, 2013-2022 ($MN)
Table 44 RoW Vitamins & minerals (salt and electrolyte) Market Analysis, by Country, 2013-2022 ($MN)
Table 45 RoW Single dose amino acid solution Market Analysis, by Country, 2013-2022 ($MN)
Table 46 RoW Parenteral lipid emulsion Market Analysis, by Country, 2013-2022 ($MN)
Table 47 RoW Carbohydrates Market Analysis, by Country, 2013-2022 ($MN)
Table 48 RoW Others (trace elements) Market Analysis, by Country, 2013-2022 ($MN)
Table 49 RoW Intravenous (IV) Solutions Market Analysis, by Type, 2013-2022 ($MN)
Table 50 RoW Peripheral Parenteral Nutrition (PPN) Market Analysis, by Country, 2013-2022 ($MN)
Table 51 RoW Total Parenteral Nutrition (TPN) Market Analysis, by Country, 2013-2022 ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report